EMPIGET-M 5/850 EMPAGLIFLOZIN 5MG/METFORMIN 850MG 28’S

Empiget-M 5/850 is a combination medication that contains Empagliflozin 5mg and Metformin 850mg. It is primarily used for the management of type 2 diabetes mellitus in adults. Empagliflozin is an SGLT2 inhibitor that helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, promoting its excretion through urine. Metformin, on the other hand, is a biguanide that enhances insulin sensitivity, reduces hepatic glucose production, and improves glucose uptake in peripheral tissues.

Together, these two active ingredients work synergistically to control blood sugar levels effectively, making Empiget-M a valuable option for patients struggling to manage their diabetes with diet and exercise alone. Additionally, it may help with weight management and has cardiovascular benefits. In Kenya, Empiget-M is an essential medication for diabetes care, contributing to better health outcomes for individuals living with this chronic condition.